z-logo
open-access-imgOpen Access
Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
Author(s) -
Luigia Rossi,
Palmarisa Franchetti,
Francesca Pierigè,
Loredana Cappellacci,
Sonja Serafini,
E Balestra,
Carlo Federico Perno,
Mario Grifantini,
R Caliò,
Mauro Magnani
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm011
Subject(s) - lamivudine , phagocytosis , in vivo , macrophage , in vitro , viral replication , virus , pharmacokinetics , biology , pharmacology , virology , chemistry , microbiology and biotechnology , biochemistry , hepatitis b virus
(i) To generate a new heterodinucleotide (3TCpPMPA) comprising the drugs lamivudine and tenofovir which have been shown to act synergistically and (ii) to protect macrophages from 'de novo' HIV-1-infection through its administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom